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Background and Aims: Oesophagectomy is the primary curative
treatment for oesophageal cancer but is associated with considerable postoperative morbidity and mortality. To better understand the aetiology of impaired health-related quality of life
(HRQL) in oesophageal cancer survivors (OCS), this study sought to
determine the longitudinal changes in nutritional status, nutritionimpact symptoms (NIS), and HRQL in this cohort, and to determine
which variables have the greatest impact on postoperative HRQL
decline.
Methods: Data, derived from St. James' Hospital, Dublin, included
patients who underwent oesophagectomy from October 2017 to
May 2019 and attended clinic preoperatively and 6 months postoperatively. A subset attended a further 12-month appointment.
HRQL and symptom data were collected using validated questionnaires and anthropometric measures were completed by clinicians. Data were analysed using SPSS.
Results: A total of 66 patients were studied preoperatively and 6
months postoperatively, of whom 37 were studied at 12 months
postoperatively. Malnutrition remained prevalent at each timepoint, although rates did not signiﬁcantly change longitudinally.
Conversely, the prevalence of malabsorption (7.6%e14.3%,
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P<0.001) and dumping syndrome (67.7%e74.3%, P¼0.003) signiﬁcantly increased with increasing time postoperatively. NIS were
signiﬁcantly associated with impaired HRQL function scores and
were independent predictors of global quality of life (gQOL) score
postoperatively (P¼0.004). A diagnostic threshold of gastrointestinal symptom severity (11.5) that identiﬁes patients at risk of
impaired gQOL was therefore reported.
Conclusion: Malnutrition and NIS are prevalent postoesophagectomy, the latter signiﬁcantly associated with reduced
HRQL. Targeted intervention in those with severe NIS could be
highly beneﬁcial, highlighting the need for dietetic input in OCS.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction
An oesophageal cancer (OC) diagnosis is commonly associated with a poor prognosis, often a
reﬂection of presentation with advanced or metastatic disease. Even where patients can be treated
with curative intent, the pathway may be arduous with extensive treatment requirements, including
preoperative (neoadjuvant) therapy and major cancer surgery [1]. The operation of oesophagectomy is
the primary curative treatment for OC and is an exemplar of complex surgery [2,3], associated with
considerable risk of major postoperative morbidity [4] and health-related quality of life (HRQL)
impairment [5e8]. Advances in the modern era [1] have enabled improved 5-year survival rates in
patients that undergo oesophagectomy [9] to approximately 50 per cent. Accordingly, with increased
numbers of survivors, survivorship and HRQL have become important outcome measures [10e14]; and
in this context, nutritional health is a key metric [13].
The importance of nutrition in survivorship of this cohort is highlighted in the Lasting Symptoms
after Esophageal Resection (LASER) study, which found that two-thirds of oesophageal cancer survivors (OCS) have long-term, functional symptoms attributable to surgery, with many closely linked to
nutritional issues [15]. The global health status and HRQL of these patients have thus been reported to
be signiﬁcantly lower than that of healthy populations, various cancer cohorts, and pre-treatment OC
patients [16], and it is rare that they return to baseline. There is a spectrum of recovery; for instance,
Sun et al. reported a HRQL recovery period of 6e12 months [17], while Derogar and Lagergren reported
6e36 months with a subgroup of patients whose HRQL deteriorates over time due to more symptoms
and worse functioning [18]. Symptoms mainly comprise those which impede oral intake, known as
nutrition-impact symptoms (NIS) [19]. These are long-lasting [17,20] and associated with poor survival
[21]; highlighting the prognostic value of their identiﬁcation [22].
Weight loss, dumping syndrome (DS) and malabsorption are key factors underpinning NIS. Body
weight loss (BWL) is almost universal in this cohort, despite dietetic support and supplementation [23].
The inability to swallow (dysphagia), which characterises the presentation of OC in many patients, is a
key factor, as well as tumour-mediated cachexia and the consequences of neoadjuvant therapies [24,25].
Postoperatively, changes in anatomy and physiology, particularly gastrointestinal and hormonal physiology, underpin the pathophysiological BWL observed [23,26]. Signiﬁcant reductions in weight,
including fat mass, skeletal muscle mass (SMM), and bone mineral density, at postoperative time-points
compared to preoperatively are consistently reported [11,13,23,27e31]. Weight loss is most pronounced
in the immediate 6 months post-oesophagectomy [11,32] with a reported 40e62% of patients losing
greater than 10% of body weight and BMI during this time [11,12,23,33]. Loss of SMM is a key component,
reported in 75% of patients at 6 months postoperatively [34]. Following this time-period, however, BWL
[27] and SMM loss [31] can continue with a negative impact on prognosis and survival [23,34,35].
A NIS-related consequence of the mechanics of oesophagectomy, including a vagotomy and pyloroplasty, is DS [11,36]. The symptoms manifest as early or late DS with distinct pathophysiology [36]. In
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early DS, reduced stomach reservoir capacity results in rapid transit of voluminous and hyperosmotic
chyme into the intestinal luminal space after food ingestion. This triggers duodenal distension,
intravascular ﬂuid shifts, activation of the sympathetic nervous system and gastrointestinal hormone
hypersecretion; jointly resulting in gastrointestinal, vasomotor, and haemodynamic symptoms which
occur within 10e60 minutes post-prandially [36e38]. Late DS, also called reactive hypoglycaemia,
occurs after 60e120 minutes of ingestion. Insulin hypersecretion, caused by early and excessive concentrations of glucose in the small intestine followed by a rapid rise in blood glucose levels, results in
delayed hypoglycaemia and the precipitation of adrenergic and/or neuroglycopenic symptoms. This is
augmented by the incretin-mediated increase in insulin production and sensitivity [36,38e42].
In this National Centre, a Nutrition and Survivorship Clinic was established to monitor outcomes after
OC surgery. It included detailed recording of nutritional symptoms, HRQL, and relevant laboratory
measurements of nutritional well-being at a number of time-points. The aim of this report is to investigate the associations between nutritional status, NIS and HRQL in a cohort of OCS from the clinic. The
objectives were threefold: ﬁrst, to describe the prevalence of and longitudinal changes in malnutrition
and NIS in survivorship after curative intent OC surgery; second, to investigate whether anthropometric/
nutritional measures or NIS are associated with HRQL; and third, to identify predictors of impaired HRQL
in OCS.

Materials and methods
Data source and data collection
The data was derived from the Nutrition and Survivorship Clinic at the National Oesophageal and
Gastric Cancer Centre at St. James' Hospital, Dublin. This study includes patients who underwent oesophagectomy for OC between October 2017 and May 2019 and attended clinic preoperatively and 6
months postoperatively. A subset of patients attended a further 12-month clinic appointment. The
preoperative and perioperative care of patients at this centre has been previously described [13]. Standard nutritional therapy involved exclusive jejunostomy feeding for 5 days postoperatively, commencing
on the ﬁrst postoperative day, which progressed slowly to half portions of easy to chew texture diet [43].
Patients were discharged on consuming half portions, overnight jejunostomy feeding, and oral nutritional supplements as required. Participant exclusion criteria included non-carcinoma related oesophagectomy, and disease recurrence or death prior to the 6-month postoperative appointment.
All patient data was collected prospectively at clinic visits. Ethical approval was obtained from the
Hospital ethics committee. Reference population HRQL data was obtained from the European Centre
for Research and Treatment of Cancer (EORTC) and other publications considered most appropriate
[44,45]. Prior to clinic visits, patients had HRQL and symptom questionnaires posted to them to be
completed before arrival. These included the general EORTC Quality of Life Questionnaire C30 (QLQC30), the OC speciﬁc EORTC QLQ-OG25, a modiﬁed Gastrointestinal Symptom Rating Scale (mGSRS),
and the Sigstad dumping questionnaire [46]. At the survivorship clinic, anthropometric measurements and micronutrient screening were completed, and treatment and follow-up arranged as
appropriate.
Nutritional and quality of life outcomes
BWL was classiﬁed according to the Blackburn criteria [47] and BMI was categorized according to
the World Health Organisation [48]. Malnutrition was deﬁned by nutritional risk index (NRI);
(1.489*serum albumin [g/L])þ(41.7*current weight/usual weight) [49], which has previously deﬁned
malnutrition in gastrointestinal cohorts [50e52]. Thresholds for classiﬁcation of nutritional status are
as follows; 100, well-nourished; 97.5e100, mild malnutrition; 83.5e97.5, moderate malnutrition;
<83.5, severe malnutrition [53]. Malabsorption was indicated by a steatorrhoea-speciﬁc score >7, as
assessed by speciﬁc questions in the mGSRS [27]. Finally, hand grip strength was measured on each
hand three times, and the highest value was used as a functional surrogate for ‘probable sarcopenia’
using previously described sex-speciﬁc and BMI-dependant thresholds [54].
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Assessment of NIS was limited to those assessed in the mGSRS (cramps, bloating, wind, belching,
borborygmi, reﬂux, anorexia, nausea, vomiting, urgency to open bowels, incomplete passing of stool, oily
stools, ﬂoating stools, and foul-smelling stools). Symptoms were assessed using a 4-point Likert scale and
an estimate of symptom frequency and severity was found by totalling the scores. Dumping syndrome
(DS) was assessed using Sigstad's scoring system where points are allocated to speciﬁc symptoms whose
presence or absence were indicated by patients. Those with a total score greater than 7 were deﬁned as
having DS whereas those with a score less than or equal to 7 were deﬁned as not having DS [55].
Quality of life outcomes included HRQL, which is an indication of one's function and level of
symptomology [56], and global quality of life (gQOL), a measure of self-perceived health status. These
were both recorded using the disease-speciﬁc and validated EORTC QLQ-C30 and QLQ-25 scales [57].
Statistical analysis
Data were analysed using SPSS software (IBM 27.0 for Windows, SPSS Inc, Chicago, IL). Continuous
variables were assessed for normality using the Shapiro-Wilk test, and data are reported as mean,
standard deviation (SD) or median, range as appropriate. Frequency data are presented as number (n),
valid percent (%); where missing values are excluded from the prevalence analysis. Comparison of
prevalence between groups was performed using the Chi-squared test. All EORTC questionnaire responses were previously linearly transformed as per the scoring manual [58]. Average differences in
HRQL scores were classed as clinically relevant as per the evidence-based interpretation guidelines,
available for inter- [59] and intra-group [60] comparison. These guidelines were developed using
robust methodology to improve clinical interpretation of score differences, and, in the present study,
differences were classed as clinically relevant if within the medium or large range [59].
Spearman's rank correlation was used in correlation analyses, as, consistently, at least one variable was non-normally distributed. Univariable comparisons within groups over two time-points
were performed using paired t-tests or Wilcoxon signed-rank tests for continuous variables, and
McNemar's test for dichotomous variables. For between group comparisons, the Mann-Whitney U
test was used. For comparing data over three time-points, Cochran's Q test, one-way repeated
measure ANOVA, or Friedman's test were performed, as appropriate. Receiver operating characteristic (ROC) curves were used to determine thresholds of continuous variables that may predict
dichotomous outcomes. Standard single or multiple linear regression was used to investigate predictors of continuous outcomes, with independent variables inputted into the model based on their
perceived clinical relevance. A signiﬁcance level of 0.05 was used for all analyses and reported P
values are two-tailed.

Results
Characteristics of the study cohort
The characteristics of the 6-month and 12-month cohort are shown in Table 1. Sixty-six patients
were studied at the 6-month time-point, of whom 37 attended at 12 months postoperatively. Preoperative data was originally collected on 75 patients [13], resulting in an inclusion rate of 88% at 6
months and 49% at 12 months. The primary documented reasons for drop-out were disease recurrence
and participants not reaching the 12-month postoperative time-point at the time of analysis. Their
mean age was 63.3, the majority were male, and approximately half were ex-smokers. For more than
80% of patients in each cohort, OC was their ﬁrst malignancy diagnosis with adenocarcinoma being the
primary histological subtype. Neoadjuvant therapy and surgery was the main treatment approach,
with preoperative chemotherapy and radiation therapy (CROSS protocol) and radical 2-stage en bloc
oesophagectomy the most common combination. Over half the patients experienced a postoperative
complication, and 22.7% and 18.9% of the 6 and 12-month cohort, respectively, experienced a
complication classiﬁed as 3 according to the Clavien-Dindo Classiﬁcation (CDC) system [61]. Tumour
recurrence after last clinic appointment was documented in 15.2% at 6 months and 8.1% at 12 months
postoperatively.
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Figure 1. A clinic visit ﬂow diagram outlining patient attendance at the Survivorship clinic.
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Table 1
Demographic, clinicopathologic and treatment characteristics of the cohort of patients who attended their preoperative,
6-month postoperative, and 12-month postoperative appointment at the Nutrition and Survivorship Clinic
Variable

Preoperative
cohort (n¼75)

6-month
cohort (n¼66)

12-month
cohort (n¼37)

63, 84.0%
12, 16.0%
62.7, 10.3%

55, 83.3%
11, 16.7%
63.3, 9.9

32, 86.5%
5, 13.5%
63.3, 9.9

13, 17.3%
35, 46.7%
24, 32.0%
3, 4.0%

10, 15.2%
31, 47.0%
22, 33.3%
3, 4.5%

5, 13.5%
19, 51.4%
13, 35.1%
0, 0.0%

12, 16.0%
9, 12.0%
17, 22.7%
35, 46.7%
2, 2.7%

8, 12.1%
9, 13.6%
15, 22.7%
32, 48.5%
2, 3.0%

4, 10.8%
5, 13.5%
7, 18.9%
21, 56.8%
0, 0.0%

8, 10.7%
51, 68.0%
16, 21.3%

8, 12.1%
44, 66.7%
14, 21.2%

4, 10.8%
24, 64.9%
9, 24.3%

10, 13.3%
62, 82.7%
3, 4.0%
29, 38.7%

10, 15.2%
53, 80.3%
3, 4.5%
26, 39.4%

6, 16.2%
31, 83.8%
0, 0.0%
17, 45.9%

64, 85.3%
11, 14.7%

56, 84.8%
10, 15.2%

31, 83.8%
6, 16.2%

13, 17.3%
57, 76.0%
3, 4.0%
1, 1.3%
1, 1.3%

13, 19.7%
48, 72.7%
3, 4.5%
1, 1.5%
1, 1.5%

8, 21.6%
26, 70.3%
2, 5.4%
1, 2.7%
0, 0.0%

25, 33.3%
8, 10.7%
20, 26.7%
22, 29.3%

22, 33.3%
6, 9.1%
15, 22.7 %
23, 34.8%

8, 21.6%
6, 16.2%
7, 18.9%
16, 43.2%

20, 26.7%
42, 56.0%
13, 17.3%

19, 28.8%
36, 54.5%
11, 16.7%

12, 32.4%
20, 54.1%
5, 13.5%

44, 58.7%
31, 41.3%
18, 24.3%

38, 57.6%
28, 42.4%
15, 22.7%

20, 54.1%
17, 45.9%
7, 18.9%

11, 14.7%
64, 85.3%

10, 15.2%
56, 84.8%

7, 18.9%
30, 81.1%

12, 16.0%
63, 84.0%

10, 15.2%
56, 84.8%

3, 8.1%
34, 91.9%

Demographic Characteristics
Sex
Male (n, %)
Female (n, %)
Age at surgery (mean, SD)
Smoking status
Current smoker (n, %)
Ex-smoker >1year (n, %)
Never smoked (n, %)
Unknown/not speciﬁed (n, %)
Alcohol intake
Non-drinker (n, %)
Ex-drinker (n, %)
Heavy drinker (>14/21UPW) (n, %)
Social drinker (<14/21UPW) (n, %)
Unknown/not speciﬁed (n, %)
Clinicopathologic and Treatment Characteristics
ASA grade at diagnosis
1 (n, %)
2 (n, %)
3 (n, %)
Previous malignancy
Yes (n, %)
No (n, %)
Unknown/not speciﬁed (n, %)
Barrett's oesophagus (n, %)
Tumour histology
Adenocarcinoma (n, %)
Squamous cell carcinoma (n, %)
Main curative treatment
Surgery (n, %)
Neoadjuvant therapy and surgery (n, %)
Surgery and endoscopic treatments (n, %)
Surgery and adjuvant therapy (n, %)
Surgery and radical CT/RT (n, %)
Neoadjuvant therapy type
CROSS (n, %)
MAGIC (n, %)
FLOT (n, %)
Not speciﬁed/Did not receive (n, %)
Surgery type
Transhiatal oesophagectomy (n, %)
2-Stage oesophagectomy (n, %)
3-Stage oesophagectomy (n, %)
Postoperative complication
Yes (n, %)
No (n, %)
CDC 3 (n, %)
Postoperative readmission
Yes (n, %)
No (n, %)
Recurrence
Yes (n, %)
No (n, %)

ASA indicates American Society of Anaesthesiologists; CDC, Clavien-Dindo Classiﬁcation; CT/RT, chemotherapy/radiotherapy;
SD, standard deviation; UPW, units per week.
CROSS protocol: weekly carboplatin and paclitaxel administration with concurrent Gy radiotherapy for 5 weeks. MAGIC protocol: perioperative triplet regimen of epirubicin, cisplatin, and ﬂuorouracil. FLOT protocol: perioperative triplet regimen of
docetaxel, oxaliplatin, leucovorin, and ﬂuorouracil.
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Table 2
Longitudinal anthropometric changes in the 12-month cohort
P

P

Variable

Preop
(n¼37)

6 months
(n¼37)

12 months
(n¼37)

P

P

Weight, kg (mean, SD)
BMI, kg/m2 (mean, SD)
BMI >25 kg/m2 (n, %)
NRI (mean, SD)
Mild Malnutrition (n, %)
Moderate Malnutrition (n, %)
Severe Malnutrition (n, %)
Grip Strength (r),
kg (mean, SD)
Grip Strength (l),
kg (mean, SD)
MUAC, cm (mean, SD)
Waist Circumference, cm
Hip Circumference, cm
Waist: Hip ratio,
(median, range)
% BWL (mean, SD)
>10% BWL (n, %)
Probable Sarcopenia (n, %)

80.3, 14.6
27.4, 4.6
26, 70.3%
105.5, 7.1
4, 10.8%
2, 5.4%
1, 2.7%
33.0, 7.8

73.2, 12.0
24.9, 3.4
19, 51.4%
102.5, 5.0
9, 24.3%
4, 10.8%
0, 0%
31.2, 7.3

72.9, 12.7
24.8, 3.8
17, 45.9%
103.1, 4.9
7, 18.9%
4, 10.8%
0, 0%
32.6, 8.1

<0.001b
<0.001b
0.001c
0.039b
0.257c
0.641c
0.368c
0.217b

<0.001b
<0.001b
0.007c
0.040b

30.7, 8.3

31.2, 6.9

30.6, 8.4

0.897b

26.9, 2.2
94.0, 64e106þ
96.7, 65e108þ
0.9, 0.8e1.0

26.9, 2.5
90.9, 11.9#
97.5, 6.6#
0.9, 0.8e1.2

0.852d
0.704e
0.992e
0.629e

8.4, 5.8
14, 37.8%
12, 32.4%

8.8, 7.1
16, 43.2%
11, 29.7%

0.487d
0.727f

7, 35%a

(preop vs 6m)

(preop vs 12m)

<0.001b
<0.001b
<0.001c
0.164b

(6m vs 12m)

1.000b
1.000b
0.439c
0.737b

0.472c

BMI indicates body mass index; BWL, body weight loss; l, left; MUAC, mid-upper arm circumference; NRI, nutritional risk index;
Preop, preoperatively; r, right; SD, standard deviation; vs, versus. Bold indicates where longitudinal changes are
signiﬁcant (P<0.05).
#
mean, SD, þmedian, range.
a
Probable sarcopenia measures available in n¼20 preoperatively.
b
One-way repeated measures ANOVA and post-hoc test signiﬁcance result.
c
Cochran's Q and post-hoc test signiﬁcance result.
d
Paired sample t-test signiﬁcance result.
e
Wilcoxon signed-rank test signiﬁcance result.
f
McNemar's test signiﬁcance result.

The prevalence of malnutrition, as per NRI, was 24.2% preoperatively and 37.9% 6 months postoperatively in the 6-month cohort, and was 29.7% at 12 months postoperatively. Longitudinal changes
in anthropometric and nutritional measurements in the 12-month cohort are shown in Table 2. Mean
weight and BMI signiﬁcantly decreased over time, reﬂected by a signiﬁcant decrease in the prevalence
Table 3
Gastrointestinal Symptoms as measured by the mGSRS at 6 and 12 months postoperatively
Symptom

Cramps
Bloating
Wind
Belching
Borborygmus
Reﬂux
Anorexia
Nausea
Vomiting
Urgency to open bowels
Incomplete passing of stool
Oily stool
Floating stool
Foul-smelling stool
Sleep disturbance due to bowels

n, % of patients who scored 2 or 3

Sig of the difference in scores from
6-12 months in 12-month cohort

6 months (n¼66)

12 months (n¼36a)

P

9, 13.6%
9, 13.6%
17, 25.7%
12, 18.2%
10, 15.5%
(n¼65) 9, 13.8%
(n¼65) 12, 18.4%
11, 13.6%
0, 0%
5, 7.6%
5, 7.5%
(n¼65) 6, 9.2%
7, 10.6%
9, 13.7%
0, 0%

(n¼35) 4,
(n¼35) 3,
8, 22.2%
8, 22.3%
3, 8.4%
2, 5.6%
(n¼35) 4,
3, 8.4%
0, 0%
4, 11.1%
(n¼35) 4,
(n¼35) 4,
2, 5.6%
6, 16.6%
(n¼35) 1,

0.513
0.090
0.467
0.132
0.808
0.739
0.109
0.475
0.655
0.467
0.660
0.564
0.480
0.218
0.739

P, signiﬁcance result of Wilcoxon signed-rank test; Sig, signiﬁcance.
a
n¼1 missing data at 12 months postoperatively.
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Table 4
The clinical relevance of statistically signiﬁcant differences in HRQL scores between patients with and without dumping
syndrome
HRQL item

Physical function
Social function
Fatigue
Dyspnoea
Eating restrictions
Trouble enjoying
meals
Pain and
discomfort

6 months (n¼65)

12 months (n¼35)

P
Dumping Nonsyndrome dumping
(median) syndrome
(median)

P
Clinically Dumping NonMedian
relevant syndrome dumping
score
(median) syndrome
difference (EBIG)
(median)

Clinically
Median
relevant
score
difference (EBIG)

83.33
66.67
33.33
33.33
25.00
33.33

100
100
11.11
0
8.33
0

0.005
0.001
<0.001
0.001
0.011
0.007

16.67
33.33
22.22
33.33
16.67
33.33

Yes
Yes
Yes
Yes
Yes
Yes

83.33
83.33
33.33
33.33
25
33.33

100
100
11.11
0
8.33
0

0.046
0.011
0.004
0.016
0.038
0.028

16.67
16.67
22.22
33.33
16.67
33.33

No
Yes
Yes
Yes
Yes
Yes

33.33

16.67

0.001

16.66

Yes

33.33

16.67

0.038 16.66

Yes

P, signiﬁcance result of Mann-Whitney U test.
EBIG, Evidence-based Interpretation Guidelines (Fig. 1).

of overweight/obesity. Mean NRI score also signiﬁcantly decreased from preoperatively to 6 months,
yet the majority of malnourished patients remained in the ‘mild malnutrition’ category. Severe BWL
was identiﬁed in 37.8% at 6 months and 43.2% at 12 months, and probable sarcopenia was diagnosed in
35%, 32.4% and 29.7% at the respective time-points.
Nutrition-impact symptoms (NIS) and dumping syndrome (DS)
Nutrition-impact symptoms remained prevalent throughout the postoperative period, with 41%
and 36% of patients reporting >2 bothersome symptoms (scored a 2 or 3 on a 0e3 Likert scale) at 6 and
12 months, respectively. In the 12-month cohort, scores for individual symptoms did not signiﬁcantly
change from 6 to 12 months (Table 3), nor did average total mGSRS score (11.1 versus 10, P¼0.523). The
prevalence of malabsorption increased from 7.6% at 6 months to 14.3% at 12 months (P<0.001).
Mean Sigstad score (SS) was 9.45 at 6 months and 8.91 at 12 months. The prevalence of DS, deﬁned
by SS>7, signiﬁcantly increased from 67.7% (44/65) to 74.3% (26/35) from 6 to 12 months (P¼0.003).
There were no signiﬁcant differences in the prevalence of DS between sexes.
Health-related quality of life
Mean HRQL scores of various populations are shown in supporting information Table 1, and clinically relevant differences between groups [59] are marked. Clinically relevant improvements [60] in
dyspnoea and appetite loss were found from 6 to 12 months in the 12-month cohort, whereas statistically signiﬁcant improvements were found for emotional function, nausea and vomiting, dyspnoea,
appetite loss, dysphagia, and taste changes.
A gQOL score of <66.1, the general population reference score [45], was set as the threshold for
impaired gQOL. This was found in 20% and 14.3% of the population at 6 and 12 months, respectively.
The demographic and clinicopathologic characteristics of those with and without impaired gQOL were
compared (data not shown). At both time-points, patients with impaired gQOL had higher Sigstad,
steatorrhoea-speciﬁc, and total mGSRS scores. All other variables assessed, including sex, age, smoking/
alcohol status, and anthropometric measurements, did not differ signiﬁcantly between those with and
without impaired gQOL.
Nutritional status and HRQL
HRQL did not differ between those with and without a BMI 25kg/m2, apart from ‘worry about
weight loss’ at 6 months, which was signiﬁcantly higher in the under/normal weight cohort compared
to the overweight/obese cohort (P¼0.022). Sarcopenic patients had several higher symptom scores
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Figure 2. Simple scatter plots of the correlations between total mGSRS score and global QOL score at 6 and 12 months
postoperatively.

postoperatively, and an increased gQOL at 6 months (P¼0.029), compared to non-sarcopenic patients
(supporting information Table 2). Several weak correlations (<0.4) were found between NRI score
and HRQL scores, suggesting worsening of HRQL with decreasing NRI score (supporting information
Table 3).
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Figure 3. Receiver operating characteristic curves between total mGSRS score and impaired global QOL at 6 and 12 months
postoperatively.

Dumping syndrome and HRQL
Numerous HRQL scores signiﬁcantly differed at each postoperative time-point, both statistically as
well as clinically, between those with and without DS, as shown in Table 4. Items that scored worse in
patients with DS at both time-points were physical function (P¼0.005/0.046), social function (P¼0.001/
0.011), fatigue (P<0.001/¼0.004), dyspnoea (P¼0.001/0.016), eating restrictions (P¼0.011/0.038),
trouble enjoying meals (P¼0.007/0.028), and pain and discomfort (P¼0.001/0.038). Similarly, several
signiﬁcant correlations were found between SS and HRQL scores which showed that increasing SS has a
negative impact on HRQL (supporting information Table 4). Strong correlations (0.5) were found
between SS and fatigue at 6 months (0.649, P<0.001), and social function (-0.518, P¼0.001), fatigue
(0.506, P¼0.002), and dyspnoea (0.522, P¼0.001) at 12 months.
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Figure 4. Simple scatter plot of 6-month total mGSRS score and 12-month global QOL score in the 12-month cohort.

Nutrition-impact symptoms and HRQL
Supporting information Table 4 displays the correlations between total mGSRS score and HRQL
scores. At both postoperative time-points, strong correlations (0.5) were found between mGSRS score
and gQOL score (-0.526, P<0.001; -0.582, P<0.001 [Figure 2]), cognitive function (-0.538, P<0.001;
-0.636, P<0.001), insomnia (0.566, P<0.001; 0.506, P¼0.002), eating restrictions (0.546, P<0.001; 0.672,
P<0.001), and odynophagia (0.516, P<0.001; 0.599, P<0.001). These correlations suggested worsening
of HRQL with increased NIS. Malabsorption also had a signiﬁcant negative impact on several HRQL
items (supporting information Table 5), including cognitive function (P¼0.031/0.014).
ROC curves were used to determine a threshold for total mGSRS score that indicates impaired gQOL
(<66.1). As shown in Figure 3, the area under the curve (AUC) between total mGSRS score and impaired
gQOL at 6 and 12 months was 0.804 (CI:0.677e0.931, P¼0.001) and 0.843 (CI:0.666e1.00, P¼0.015),
supporting it as a good diagnostic test. A threshold of 11.5 was selected as the sum of sensitivity and
speciﬁcity was as closest to, or above, 1.5 at each time-point, as recommended by Power et al. [62]
(sensitivity/speciﬁcity: 76.9%/71.2% at 6 months, 80%/80% at 12 months).
A bivariate regression analysis was conducted to examine how well 6-month total mGSRS score
could predict gQOL score at 12 months. The scatterplot between these two variables, shown in Figure 4,
revealed one outlier which was removed from the analysis: resulting in a sample size of 34. The
Spearman correlation between the two variables was -0.586 (P<0.001), the regression equation for
predicting 12-month gQOL score was 98.589-1.861(6-month mGSRS score) (P<0.001), and the adjusted
r2 was 0.508.
Predictors of HRQL
Standard multiple linear regression was performed to assess the impact of a set of predictor variables on gQOL score (Table 5). Predictor variables were selected based on plausibility to impact HRQL
and results of previous analyses, and included NRI, Sigstad score (SS), steatorrhoea-speciﬁc score,
mGSRS score, whether the patient had a postoperative complication of CDC3 and whether the patient
had a preoperative ASA grade of 3. At 6 months, the model explained 41.1% of variance in gQOL score
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Table 5
Multiple linear regression analysis of predictor variables for global quality of life score at 6 and 12 months postoperatively
Predictor Variable

6 months
Beta
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Nutritional risk index
Sigstad score
Steatorrhoea-speciﬁc score
mGSRS score
CDC3
ASA grade of 3
Model Summary

12 months
CI

0.033
-0.588e0.821
-0.127
-1.195e0.335
0.079
-1.573e2.557
-0.572
-3.163e-0.628
0.189
-0.889e17.785
-0.285
-22.228e-3.898
Adjusted R square: 0.411 (P<0.001)

P

[Part]2 x100

Beta

0.741
0.265
0.635
0.004
0.075
0.006

0.10
1.17
0.21
8.24
3.03
7.51

0.199
-0.336e1.592
-0.401
-2.251e-0.301
-0.342
-4.515e0.990
-0.095
-1.697e1.225
-0.026
-11.117e13.196
-0.136
-15.482e5.731
Adjusted R square: 0.387 (P¼0.003)

CI

P

[Part] [2]
x100

0.192
0.012
0.200
0.743
0.862
0.354

3.31
13.40
3.20
0.20
0.06
1.66
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ASA, American Society of Anaestheologists; Beta, standardised beta coefﬁcient; CDC, Clavien-Dindo Classiﬁcation; CI, conﬁdence interval; mGSRS, modiﬁed Gastrointestinal Symptom
Rating Scale; P, signiﬁcance value; Part, semipartial correlation coefﬁcient. Bold indicates where longitudinal changes are signiﬁcant (P<0.05).
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(P<0.001). Total mGSRS score (b [CI]: -0.572 [-3.163 e -0.628], P¼0.004) and ASA grade equalling 3 (b
[CI]: -0.285 [-22.228 e -3.898], P¼0.006) independently contributed to the model equation and,
together, explained 15.75% of gQOL variance. At 12 months, the model explained 38.7% of variance in
gQOL score (P¼0.003), with SS independently contributing to the model equation (b [CI]: -0.401 [-2.251
e -0.301], P¼0.012) and explaining 13.40% of gQOL variance.
Discussion
With improved survival rates in OC treated with curative intent, HRQL has become a major focus of
research and an intervention target to enhance recovery and optimise survivorship [11,34]. Nutritional
health is central to this goal in this cohort of patients. An understanding of nutrition in HRQL will also
provide evidence-based information for clinical decision-making and for resourcing optimal care
pathways [63]. This study has shown that malnutrition, NIS, and DS are prevalent in OCS, and that NIS
and DS are signiﬁcantly associated with reduced HRQL. This highlights numerous modiﬁable targets.
Collection of information on outcomes from a patient perspective is an accepted part of oncological
research [64], particularly in OC [65], and is facilitated through HRQL questionnaires. Responses can
inform preoperative patients on what to expect postoperatively, guide standard advice [5,63], and
identify patients requiring further intervention [21]. Moreover, postoperative HRQL scores, including
gQOL and physical function, are independent predictors of long-term survival in OCS [21,66]. The HRQL
of this cohort was comparable to the reference general population, which is an unusual ﬁnding
compared to previous publications [16,67], particularly regarding physical function [5,68e70]. The
survivorship clinic may be a factor, which provided contact with dietetic professionals through the ﬁrst
year of survivorship. This is consistent with increases in gQOL and physical function reported in other
cancer types when patients have this level of nutritional and dietetic support [71]. Emotional function
was higher in the sample cohort compared to reference populations at 12 months postoperatively, and
it signiﬁcantly improved from 6-month scores. This effect of treatment completion on emotional
function has been reported elsewhere [5,63,72], and is possibly related to the feeling of optimism from
the recovery process after they have undergone curative intent surgery [63].
Notwithstanding encouraging gQOL and function scores observed, most patients have a considerable symptom burden. Some patients with a high level of symptomology report good HRQL scores,
however a subset still reported impaired gQOL. Independent risk factors for this included increased
Sigstad, steatorrhoea-speciﬁc, and mGSRS score, but neither demographic nor clinicopathologic factors. As these risk factors are all related to gastrointestinal function, the beneﬁt of comprehensive and
intensive nutritional management in this cohort is further highlighted.
Extensive gastrointestinal resection and reconstruction, an inherent consequence of oesophagectomy, increases the risk of malnutrition postoperatively [33,34], which is associated with reduced
HRQL and survival [16,73e76]. At 1-year postoperatively, the prevalence of malnutrition in this cohort
was 43.2% when deﬁned by BWL >10%, and 29.7% as per NRI. This is lower than what is reported in
similar studies [33,74,77], possibly achieved through postoperative jejunostomy feeding for typically
one month post-discharge, dietetic interventions, and increased monitoring via the survivorship clinic.
It is worth noting that evidence supporting the use of malnutrition assessment tools such as the
Patient-Generated Subjective Global Assessment tool [78] and the Global Leadership Initiative on
Malnutrition tool [79] is superior to the NRI [80,81]. However, the NRI was used to allow for comparisons with previous publications on oesophageal cancer cohorts from this [27] and other centres
nationally [82,83]. Furthermore, the volume of subjective participant questionnaires employed in this
study indicated use of a straightforward, objective malnutrition screening tool such as the NRI, which
carries limited evidence suggesting its utility [84e86].
Probable sarcopenia prevalence did not signiﬁcantly increase postoperatively despite postoperative
BWL, suggesting loss of fat mass was greater than SMM in this cohort. As sarcopenia is negatively
associated with overall survival [87,88] and major morbidity [31], this is a positive, clinically relevant
ﬁnding. Notwithstanding, it is worth considering that using hand grip strength as a surrogate for
sarcopenia does not follow European clinical consensus guidelines [89] and may have underestimated
its prevalence. It was for this reason that the term ‘probable sarcopenia’ was used throughout the
present study.
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Vagal denervation and endogenous neuroendocrine signal loss can result in exocrine pancreas
insufﬁciency post-oesophagectomy [76]. In this study, the prevalence of malabsorption signiﬁcantly
increased from 6 to 12 months postoperatively. Malabsorption and steatorrhoea contribute to
malnutrition through nutrient loss, especially of fat soluble vitamins, so identifying patients and
treatment with pancreatic enzymes is both essential and effective [27]. It has not been previously
investigated whether the overall effect of steatorrhoea reduces HRQL [90], where present study found a
reduction in several HRQL scores, including cognitive function. This association warrants further
investigation and may be related to fat soluble vitamin [91] and/or other micronutrient deﬁciency
[92,93].
Although many nutritional parameters were better than reported in previous studies, the prevalence of DS was high. There may be many contributing factors, including the routine use of pyloroplasty
in patients at this centre, which may accelerate gastric emptying. A key element is likely the detailed
prospective evaluation of relevant symptoms in each patient, something which we suspect is not
standard practice outside of such structures and clinical research [13]. Moreover, it is clear that an
inconsistency in assessment and diagnostic methods for DS limits reliable comparisons between
studies [94]. Importantly, DS was strongly associated with HRQL, principally fatigue and social function.
Social function recovery is essential as it allows OCS to separate themselves from the identity of a
‘cancer patient’ [95], but unpleasant social interactions and anxiety associated with DS may impede
this [38]. Taken together, these ﬁndings conﬁrm that dumping syndrome is a major, prevalent problem
after oesophagectomy that requires objective, evidence-based diagnosis, management, and treatment
guidelines. Management and treatment may be aided by novel interventions, such as continuous
glucose monitoring, which could be a useful tool in the diagnosis and management of reactive
hypoglycaemia [96]. It may also facilitate strategies to reduce the impact of dumping on HRQL, especially social and cognitive function [97].
Nutrition-impact symptoms are key contributors to malnutrition [11], and it is known that they
reduce HRQL [98e101]. However, this has rarely been explicitly studied in OCS. This may be because
the symptom pattern of OCS as they recover is unclear [102] and holds inter-individual variability.
The present study found that symptoms do not improve from 6 to 12 months postoperatively, suggesting lack of adaption of the gastrointestinal tract to anatomical changes in the ﬁrst year after
surgery. Total mGSRS score was strongly correlated with numerous HRQL scores at both postoperative
time-points, including gQOL, and it independently contributed to variance in gQOL at 6 months.
Therefore, a total mGSRS score threshold for identifying those whose HRQL could beneﬁt from
specialised nutritional input was determined. This mGSRS test is patient-centred, timely, and efﬁcient; thus fulﬁlling the requirements of a high-quality test as reported by Power et al. [62]. This study
also revealed it to be a sensitive and speciﬁc screening tool for use in clinical practice, allowing those
at highest risk of impaired gQOL to be referred for targeted symptom management intervention. It
was also found that 12-month gQOL score could be predicted by the 6-month mGSRS score using the
reported equation. This would allow an opportunity for early intervention in those identiﬁed as high
risk of impaired HRQL with the aim of reducing their symptom burden by the 12-month postoperative time-point.
The strengths of this study include detailed, prospective data collection at a dedicated structured
clinic [13] and the use of validated questionnaires [10,103], which minimise information bias. Additionally, assessment at two postoperative time-points allowed for more rigorous evaluations of postoperative contributors to HRQL. We acknowledge some limitations, including a relatively modest
sample size from a single institution, and encourage result validation in a larger study group, including
the regression analyses and mGSRS threshold. Sources of potential bias include participant drop-out,
self-reporting of symptoms, and the sole inclusion of patients who remained recurrence-free
throughout the study period, introducing a survivorship bias. Notably, correction for multiple comparisons was not employed in this analysis. Tools such as Bonferroni have been criticised for being
overly restrictive and increasing the risk of Type 2 errors. In this analysis, we explored a wide spectrum
of patient outcomes and the results have been interpretated in a holistic manner, rather than focusing
on single results of signiﬁcance.
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Conclusion
This study has shown that malnutrition and DS are prevalent after OC surgery, and that NIS reduce
HRQL. The clinic structure and the study data support such programmes for these cohorts of patients,
in particular those with severe NIS. We have proposed a mGSRS threshold of >11.5, however validation
of this in a larger sample is needed. The high prevalence of DS is noted, and its detailed assessment
complimented by continuous glucose monitoring to diagnose and manage reactive hypoglycaemia
represents an important area to study. These data show that nutritional health is inextricably linked to
symptoms, HRQL, and recovery and survivorship after oesophageal cancer surgery, and strategies to
optimise the patient pathway through the treatment cycle into survivorship should create clinics with
a major focus on dietetics/nutritional health to accommodate these signiﬁcant patient needs.
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